Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Mold contamination in a controlled hospital environment: a 3-year surveillance in southern Italy

  • Giuseppina Caggiano1Email author,
  • Christian Napoli1,
  • Caterina Coretti1,
  • Grazia Lovero1,
  • Giancarlo Scarafile1,
  • Osvalda De Giglio1 and
  • Maria Teresa Montagna1
BMC Infectious Diseases201414:595

https://doi.org/10.1186/s12879-014-0595-z

Received: 25 February 2014

Accepted: 29 October 2014

Published: 15 November 2014

Abstract

Background

Environmental monitoring of airborne filamentous fungi is necessary to reduce fungal concentrations in operating theaters and in controlled environments, and to prevent infections. The present study reports results of a surveillance of filamentous fungi carried out on samples from air and surfaces in operating theaters and controlled environments in an Italian university hospital.

Methods

Sampling was performed between January 2010 and December 2012 in 32 operating theaters and five departments with high-risk patients. Indoor air specimens were sampled using a microbiological air sampler; Rodac contact plates were used for surface sampling. Fungal isolates were identified at the level of genera and species.

Results

Sixty-one samples (61/465; 13.1%) were positive for molds, with 18 from controlled environments (18/81; 22.2%) and 43 (43/384; 11.2%) from operating theaters. The highest air fungal load (AFL, colony-forming units per cubic meter [CFU/m3]) was recorded in the ophthalmology operating theater, while the pediatric onco-hematology ward had the highest AFL among the wards (47 CFU/m3). The most common fungi identified from culture of air specimens were Aspergillus spp. (91.8%), Penicillium spp., (6%) and Paecilomyces spp. (1.5%). During the study period, a statistically significant increase in CFU over time was recorded in air-controlled environments (p = 0.043), while the increase in AFL in operating theaters was not statistically significant (p = 0.145). Molds were found in 29.1% of samples obtained from surfaces. Aspergillus fumigatus was the most commonly isolated (68.5%).

Conclusions

Our findings will form the basis for action aimed at improving the air and surface quality of these special wards. The lack of any genetic analysis prevented any correlation of fungal environmental contamination with onset of fungal infection, an analysis that will be undertaken in a prospective study in patients admitted to the same hospital.

Keywords

Contamination Fungi Hospital Air Surfaces Environment

Background

Pathogenic or opportunist microorganisms in hospital environments may be a source of infection in susceptible hosts [1],[2]. This is particularly worrying in controlled environments with immunocompromised patients [3]-[5] and in operating theaters where numerous risk factors may exist, including inefficient ventilation systems and failure to follow infection control behaviors in healthcare workers [6],[7].

The air and surfaces in high-risk environments have been often studied as a source of bacterial infection [8]-[10], but regarding fungal contamination, the literature data are still limited [11]-[14]. The most common infection in fatal complications is aspergillosis in patients with hematological malignancies [15] and mucormycosis in patients with uncontrolled diabetes mellitus [16],[17]. Rare mold diseases, such as fusariosis and scedosporiosis, have also been described [18]-[20]. Filamentous fungal infections (FFIs) are serious postoperative complications in transplant recipients [21],[22], requiring particular attention by the clinician and surgeon.

Although the actual incidence of FFIs has increased worldwide, the real frequency is often underestimated because of the difficulty in determining the cause. Moreover, the lack of standardized protocols and unclear reference threshold values complicates the analysis. The aim of the present study was to analyze the presence of molds in air and on surfaces in operating theaters and controlled environments in a large hospital in southern Italy and to assess the prevalence of the different species that may affect the hospital indoor air quality.

Methods

Design study

This study was carried out from January 2010 to December 2012 in five controlled environments (intensive units of wards admitting patients with a high risk of infection) and 32 operating theaters of University Hospital, Apulia, Southern Italy (UHSI). UHSI is a 1400-bed teaching hospital providing all medical services, including a bone marrow and solid organ transplantation service and 32 turbulent air flow operating theaters. According to hospital safety protocols for controlled environments, air and surface microbiological surveillance is performed twice a year in operating theaters and once per year in controlled environments. The 32 operating theaters included eight general surgery, five specialist surgery, four gynecology, four orthopedic, three ophthalmology, three solid-organ transplantation, two otorhinolaryngology, two pediatric, and one maxilla-facial surgery. Controlled environments included a hematology unit (eight rooms), a bone marrow transplant unit (six rooms), a solid-organ transplantation unit (four rooms), a neonatal intensive care unit (NICU) (four rooms), and a pediatric onco-hematology unit (five rooms).

Air sampling

According to International Standard Organization (ISO 14698-1) [23] microbial standard procedures, air contamination was evaluated by active sampling (SAS, Aquaria Microflow, Milan, Italy) with a flow rate of 180 L/min. Because no air volume is recommended either by the ISO or the Italian Institute for Occupational Safety and Prevention [24], we sampled a suction volume of 500 L of air in one continuous drawing, based on published data [25],[6],[26].

The sampler was placed about 1 m above the floor and 1 m from the operating bed or the patient bed in stay rooms. In each operating theater, sampling was performed twice a year in the early morning before the beginning of surgical activity (at rest) to verify the efficiency of environmental cleaning systems and conditioner systems and during surgical activity (in operational) to verify the anthropic impact on environmental pollution. In the controlled environments, sampling was performed once a year in the morning after the daily cleaning. A total of 128 samples/year were collected in the 32 operating theaters, of which 64 were at rest and 64 in operational, and 27 samples/year were collected from the other controlled environments.

The presence of fungi was evaluated using plates containing Sabouraud chloramphenicol dextrose agar (SabC, Becton-Dickinson, Heidelberg, Germany). Each position was simultaneously sampled by two plates that were incubated for 10 days at 28° ±1°C. The number of colony-forming units was adjusted using the conversion table provided by the manufacturer and was expressed in colony-forming units per cubic meter (CFU/m3). The results were expressed as the mean of two plates in colony-forming units. The air fungal load (AFL) was defined as the number of captured CFU/m3 of air.

Surface sampling

Surface sampling was carried out using Rodac contact plates contained Sabouraud dextrose agar with chloramphenicol and neutralizing agents (Merck, Grenoble; Becton Dickinson, Rome) according to recommendations of the European Standard - International Organization for Standardization (EN ISO 14698-1) [23]. In controlled environments, one sampling/year was performed at the patient bedhead, wall, air-conditioning unit, night table, and ventilator in all 27 selected rooms. In operating theaters, two samplings/year were performed at the surgical lamp, wall, air-conditioning, and table in all 32 selected rooms. A total of 405 and 768 points were sampled in controlled environments and operating theaters, respectively. Each point was simultaneously sampled by two Rodac plates that were incubated for 10 days at 28° ±1°C. The results were expressed as the mean of two plates in colony-forming units per square centimeter (CFU/cm2).

Fungal identification

Genus and species of the filamentous fungi isolates were identified based on their macroscopic and microscopic morphological features, in accordance with the methods described by de Hoog [27].

The macroscopic examination was based on visual observation of morphological characteristics and color of aerial mycelium, while the microscopic analysis was performed by preparation of lactophenol cotton blue-stained slides. The slides were prepared with tape that adhered to aerial mycelium and placed on the lactophenol cotton blue-stained slides.

Statistical analysis

Statistical analysis of data was performed using SPSS 10 for Mac OS X (SPSS Inc., Chicago, IL, USA). To assess whether there was a time trend in the fungal contamination, a linear regression with the R2 test was fitted to the data.

Results

Air

Overall, 465 air samples were collected: 81 from controlled environments and 384 from operating theaters of which 192 were at rest and 192 were in operational. Sixty-one samples (61/465; 13.1%) were positive for molds, 18 from controlled environments (18/81; 22.2%), and 43 (43/384; 11.2%) from operating theaters. Filamentous fungi were isolated from air samples of two operating theaters (ophthalmology and general surgery) and three controlled environments (solid-organ transplantation unit, neonatal intensive care unit, and the pediatric onco-hematology unit) (Table 1). The highest air fungal load (AFL; CFU/m3) was recorded in the ophthalmology operating theater with 61 CFU/m3 collected in operational, while the highest AFL among the selected wards was in the pediatric onco-hematology (47 CFU/m3) (Table 2). Of 402 CFU counted on cultures of all samples, Aspergillus spp. was the most frequently recovered (369/402 CFU; 91.8%), followed by Penicillium spp., (24/402 CFU; 6%), Paecilomyces spp. (6/402 CFU; 1.5%), Zygomycetes (2/402 CFU; 0.5%), and Cladosporium spp. (1/441 CFU; 0.2%). The annual CFU of Aspergillus spp. showed an increase from year 2010 to 2012 (R2 = 0.999; p = 0.03) (Table 3, Table 4). A statistically significant increase over time was recorded in controlled environments (R2 = 0.996; p = 0.043), while the increase reported in the operating theaters was not statistically significant (R2 = 0.949; p = 0.145).
Table 1

Number (No) of positive air samples in operating theaters (OT) and controlled environments (CE) per year

Point of sampling

No. of positive air samples/year

 

2010

2011

2012

Total

Ophthalmology (OT)

7/12

6/12

12/12

25/36

General surgery (OT)

0/32

8/32

10/32

18/96

Solid organ transplantation (CE)

0/4

2/4

3/4

5/12

NICU* (CE)

2/6

0/6

5/6

7/18

Pediatric onco-hematology (CE)

0/8

2/8

4/8

6/24

*NICU = Neonatal Intensive Care Unit.

Table 2

Fungal isolates recovered in air samples from the operating theaters and controlled environments

  

Total CFU count*/year

  

Fungal isolates

2010

2011

2012

No

%

Aspergillus spp.

80

125

164

369

91.8

Penicillium spp.

 

3

21

24

6

Paecilomyces spp.

 

6

 

6

1.5

Zygomycetes

  

2

2

0.5

Cladosporium spp.

 

1

 

1

0.2

Total

80

135

187

402

100

*The number of CFU counted on cultures of all samples obtained during study.

Table 3

Fungal species recovered in air samples from the controlled environments

  

Total CFU count*/year

 

Fungal species

2010

2011

2012

%

Aspergillus niger

34

29

52

115

54

Aspergillus fumigatus

 

25

36

61

28.6

Aspergillus flavus

 

10

 

10

4.7

Penicillium notatum

 

2

15

17

8

Penicillium expansum

 

1

6

7

3.3

Mucor pusillus

  

1

1

0.5

Rhizopus arrhizus

  

1

1

0.5

Cladosporium herbarum

 

1

 

1

0.5

Total

34

68

111

213

100

*The number of CFU counted on cultures of all samples obtained during study.

Table 4

Fungal species recovered in air samples from the operating theaters

  

Total CFU count*/year

 

Fungal species

2010

2011

2012

N

%

Aspergillus fumigatus

46

47

51

144

76.2

Paecilomyces lilacinus

 

6

 

6

3.2

Aspergillus flavus

 

14

25

39

20.6

Total

46

67

76

189

100

*The number of CFU counted on cultures of all samples obtained during the study.

Surfaces

In total, 240 surfaces were sampled; 105 samples from 15 operating theatre rooms and 135 from 27 rooms of the controlled environments. Overall, 70 (29.1%) were positive for molds, 48 (68.5%) for Aspergillus fumigatus, 14 (20%) for Aspergillus niger, and 8 (11.4%) for Penicillium notatum. The most contaminated surfaces were the walls and the air conditioning units with a medium of 0.35 CFU/cm2 and 0.28 CFU/cm2, respectively.

Invasive fungal infections

During the period study, six cases of invasive fungal infection in two high-risk departments were detected. These cases were defined as probable aspergillosis according to the criteria of the European Organization for Research on the Treatment of Cancer/Mycoses Study Group [28]. Aspergillus niger in two cases and Aspergillus fumigatus in one case, were isolated from the sputum of three patients. In the other three cases of aspergillosis, the diagnosis of probable disease was based on clinical and antigen tests (galactomannan assay).

Discussion

In hospital environments, airborne molds are a potential risk for patients because of possible inhalation of conidia [29]. Because surgical procedures expose patients to infective complications, the operating theater is considered a complex habitat in which all sources of pollution have to be kept under control [21],[22]. In particular, the widespread presence of Aspergillus spp. is the major extrinsic risk factor for invasive aspergillosis, caused by A. fumigatus and other species of Aspergillus, such as A. flavus, A. niger, and A. terreus, depending on the local epidemiology [30] and according to the season [31]. In our study, the AFLs varied from 2 to 47 CFU/m3 in the controlled environments and from 0 to 61 CFU/m3 in operating theaters, with the highest value reached during surgical procedures. Although we also observed that the AFL varied throughout the year, we could not correlate the data with seasons because of the low number of samples.

The pediatric onco-hematology had the highest fungal contamination, probably because of the presence of more staff and others (parents, clowns to help conventional therapy, and psychologists) or because of the natural migration of fungal spores on the clothes of people coming from outside. This ward underwent partial reconstruction, which raised dust-rich Aspergillus spores associated with the construction of nearby buildings, internal demolition, construction, and the renovation of hospital wards. Systems for treating and humidifying air can be easily colonized and create a reservoir of spores in the indoor environment [32].

Studies seem to have confirmed a correlation between Aspergillus concentration and cases of aspergillosis. Pini et al. [33], during a surveillance of hematology wards, found extremely low concentrations of A. fumigatus in the rooms and corridors and no cases of invasive aspergillosis. More recently, Pokala et al. [14] demonstrated a correlation between a high number of airborne fungal spores and cases of invasive aspergillosis in an onco-hematology pediatric ward that underwent building renovations.

Conclusions

Although the presence of mold contamination in the healthcare environment may increase fungal infections, the lack of a genetic analysis on recovered strains prevented any correlation analysis between clinical disease and environmental isolates in our surveillance. However, the isolation of fungal strains calls for more adequate control measures. Regular surveillance and cleaning along with restriction of visitors might be among the measures necessary to reduce or totally eliminate the fungal load of indoor air. We are planning a prospective study focused on the correlation of fungal contamination with cases of fungal disease by genetic analysis of clinical and environmental strains, taking into account local epidemiological data.

Authors' contributions

GC, CN, CC, and MTM contributed to the definition of the study protocol, to the data collection, input, and analysis, and to the manuscript drafting and writing; LG, SG, and DGO contributed to the data collection, input, and analysis. All authors read and approved the final manuscript. GC: Assistant professor, CN: Assistant professor, CC: Graduated student, MTM: Full professor, LG: PHD, SG: Graduated student, DGO: PHD, Department of Biomedical Science and Human Oncology - University "Aldo Moro", Piazza Giulio Cesare 11, Bari, Italy.

Abbreviations

FFIs: 

Filamentous fungal infections

UHSI: 

University Hospital Southern Italy

ISO: 

International Standard Organization

AFL: 

Air fungal load

CFU/m3

Colony forming units per cubic meter

CFU/cm2

Colony forming units per square centimeter

Declarations

Authors’ Affiliations

(1)
Department of Biomedical Science and Human Oncology, Hygiene Section, University of Bari "Aldo Moro"

References

  1. Sehulster L, Chinn RY: Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 2003, 52: 1-42.PubMedGoogle Scholar
  2. Safe Surgery Saves Lives. 2009, World Health Organization, GenevaGoogle Scholar
  3. Hao ZF, Ao JH, Hao F, Yanf RY, Zhu H, Zhang J: Environment surveillance of filamentous fungi in two tertiary care hospitals in China. Chin Med J. 2011, 124: 1970-1975.PubMedGoogle Scholar
  4. Azie N, Neofytos D, Pfaller M, Meier-Kriesche HU, Quan SP, Horn D: The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. Diagn Microbiol Infect Dis. 2012, 73: 293-300. 10.1016/j.diagmicrobio.2012.06.012.View ArticlePubMedGoogle Scholar
  5. Montagna MT, Lovero G, Coretti C, Martinelli D, Delia M, De Giglio O, Caira M, Puntillo F, D'Antonio D, Venditti M, Sambri V, Di Bernardo F, Barbui A, Lo Cascio G, Concia E, Mikulska M, Viscoli C, Maximova N, Candoni A, Oliveri S, Lombardi G, Pitzurra L, Sanguinetti M, Masciari R, Santantonio T, Andreoni S, Barchiesi F, Pecile P, Farina C, Viale P, et al: SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients. Infection. 2014, 42: 141-151. 10.1007/s15010-013-0539-3.View ArticlePubMedGoogle Scholar
  6. Napoli C, Tafuri S, Montenegro L, Cassano M, Notarnicola A, Lattarulo S, Montagna MT, Moretti B: Air sampling methods to evaluate microbial contamination in operating theatres: results of a comparative study in an orthopaedics department. J Hosp Infect. 2012, 80: 128-132. 10.1016/j.jhin.2011.10.011.View ArticlePubMedGoogle Scholar
  7. Slekovec C, Faivre B, Humbert P, Bertrand X, Hocquet D, Pazart L, Talon D: Chronic wound care leads to the bacterial contamination of the environment. Ann Dermatol Venereol. 2012, 139: 798-802. 10.1016/j.annder.2012.09.007.View ArticlePubMedGoogle Scholar
  8. Knobben BA, van Horn JR, van der Mei HC, Busscher HJ: Evaluation of measures to decrease intra-operative bacterial contamination in orthopaedic implant surgery. J Hosp Infect. 2006, 62: 174-180. 10.1016/j.jhin.2005.08.007.View ArticlePubMedGoogle Scholar
  9. Galvin S, Dolan A, Cahill O, Daniels S, Humphreys H: Microbial monitoring of the hospital environment: why and how?. J Hosp Infect. 2012, 82: 143-151. 10.1016/j.jhin.2012.06.015.View ArticlePubMedGoogle Scholar
  10. Tang CS, Wan GH: Air quality monitoring of the post-operative recovery room and locations surrounding operating theatres in a medical center in Taiwan. PLoS One. 2013, 8 (4): e610934-Google Scholar
  11. Pini G, Donato R, Faggi E, Fanci R: Two years of a fungal aerobiocontamination survey in a Florentine haematology ward. Eur J Epidemiol. 2004, 19: 693-698. 10.1023/B:EJEP.0000036778.13006.16.View ArticlePubMedGoogle Scholar
  12. Montagna MT, De Giglio O, Napoli C, Lovero G, Caggiano G, Delia M, Pastore D, Santoro N, Specchia G: Invasive fungal infections in patients with hematologic malignancies (Aurora Project): lights and shadows during 18-months surveillance. Int J Mol Sci. 2012, 13: 774-787. 10.3390/ijms13010774.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Morace G, Borghi E: Fungal infections in ICU patients: epidemiology and the role of diagnostics. Minerva Anestesiol. 2010, 76: 950-956.PubMedGoogle Scholar
  14. Pokala HR, Leonard D, Cox J, Metcalf P, McClay J, Siegel J, Winick N: Association of hospital construction with the development of healthcare associated environmental mold infections (HAEMI) in pediatric patients with leukemia. Pediatr Blood Cancer. 2014, 61: 276-280. 10.1002/pbc.24685.View ArticlePubMedGoogle Scholar
  15. Nosari AM, Caira M, Pioltelli ML, Fanci R, Bonini A, Cattaneo C, Castagnola C, Capalbo SF, De Fabritiis P, Mettivier V, Morselli M, Pastore D, Aversa F, Rossi G, Pagano L: Hema e-chart registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections. Clin Microbiol Infect. 2013, 19: 757-762. 10.1111/1469-0691.12014.View ArticlePubMedGoogle Scholar
  16. Giglio M, Caggiano G, De Blasi R, Brienza N, Bucaria V, Ladisa P, Ceci G, Dalfino L, Montagna MT, Bruno F, Puntillo F: A fatal rhino-cerebral zygomycosis in a young woman with latent diabetes mellitus and cerebral blood vessel agenesis. Med Mycol. 2010, 48: 394-397. 10.3109/13693780903148361.View ArticlePubMedGoogle Scholar
  17. Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, Lass-Florl C, Bouza E, Klimko N, Gaustad P, Richardson M, Hamal P, Akova M, Meis JF, Rodriguez-Tudela JL, Roilides E, Mitrousia-Ziouva A, Petrikkos G: Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011, 17: 1859-1867. 10.1111/j.1469-0691.2010.03456.x.View ArticlePubMedGoogle Scholar
  18. Caggiano G, Cantisani P, Rolli M, Gianfreda CD, Pizzolante M, Montagna MT: The importance of a proper aetiological diagnosis in the management of patients with invasive mycoses: a case report of a brain abscess by Scedosporium apiospermum. Mycopathologia. 2011, 172: 317-322. 10.1007/s11046-011-9436-4.View ArticlePubMedGoogle Scholar
  19. Miceli MH, Lee SA: Emerging moulds: epidemiological trends and antifungal resistance. Mycoses. 2011, 54: 666-678. 10.1111/j.1439-0507.2011.02032.x.View ArticleGoogle Scholar
  20. Muhammed M, Anagnostou T, Desalermos A, Kourkoumpetis TK, Carneiro HA, Glavis-Bloom J, Coleman JJ, Mylonakis E: Fusarium infection: report of 26 cases and review of 97 cases from the literature. Med (Baltimore). 2013, 92: 305-316. 10.1097/MD.0000000000000008.View ArticleGoogle Scholar
  21. Partridge-Hinckley K, Liddell GM, Almyroudis NG, Segal BH: Infection control measures to prevent invasive mould diseases in hematopoietic stem cell transplant recipients. Mycopathologia. 2009, 168: 329-337. 10.1007/s11046-009-9247-z.View ArticlePubMedGoogle Scholar
  22. Grossi PA, Gasperina DD, Barchiesi F, Biancofiore G, Carafiello G, De Gasperi A, Sganga G, Menichetti F, Montagna MT, Pea F, Venditti M, Viale P, Viscoli C, Nanni Costa A: Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients. Transplant Proc. 2011, 43: 2463-2471. 10.1016/j.transproceed.2011.06.020.View ArticlePubMedGoogle Scholar
  23. Cleanrooms and associated controlled environments: biocontamination control. Part 1: general principles and methods. Document ISO 14698-1:2003. 2014, ISOGoogle Scholar
  24. Linee guida per la definizione degli standard di sicurezza e di igiene ambientale dei reparti operatori.Google Scholar
  25. Pasquarella C, Veronesi L, Castiglia P, Liguori G, Montagna MT, Napoli C, Rizzetto R, Torre I, Masia MD, Di Onofrio V, Colucci ME, Tinteri C, Tanzi M: SItI working group "Hygiene in Dentistry": Italian multicentre study on microbial environmental contamination in dental clinics: a pilot study. Sci Total Environ. 2010, 408: 4045-4051. 10.1016/j.scitotenv.2010.05.010.View ArticlePubMedGoogle Scholar
  26. Napoli C, Marcotrigiano V, Montagna MT: Air sampling procedures to evaluate microbial contamination: a comparison between active and passive methods in operating theatres. BMC Public Health. 2012, 12: 594-10.1186/1471-2458-12-594.View ArticlePubMedPubMed CentralGoogle Scholar
  27. De Hoog GS, Guarro J, Gené J, Figueras MJ: Atlas of Clinical Fungi. 2009, Centraalbureau voor Schimmelcultures (CBS), The NetherlandsGoogle Scholar
  28. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, et al: European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group: Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008, 46: 1813-1821. 10.1086/588660.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Augustowska M, Dutkiewicz J: Variability of airborne mikroflora in a hospital ward within a period of one year. Ann Agric Environ Med. 2006, 13: 99-106.PubMedGoogle Scholar
  30. Singh N, Paterson DL: Aspergillus infections in transplant recipients. Clin Microbiol Rev. 2005, 18: 44-69. 10.1128/CMR.18.1.44-69.2005.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Panagopoulou P, Filioti J, Farmaki E, Maloukou A, Roilides E: Filamentous fungi in a tertiary care hospital: environmental surveillance and susceptibility to antifungal drugs. Infect Control Hosp Epidemiol. 2007, 28: 60-67. 10.1086/508832.View ArticlePubMedGoogle Scholar
  32. Awosika S, Olajubu F, Amusa N: Microbiological assessment of indoor air of a teaching hospital in Nigeria. Asian Pac J Trop Biomed. 2012, 2: 465-468. 10.1016/S2221-1691(12)60077-X.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Pini G, Faggi E, Donato R, Sacco C, Fanci R: Invasive pulmonary aspergillosis in neutropenic patients and the influence of hospital renovation. Mycoses. 2008, 51: 117-122. 10.1111/j.1439-0507.2007.01453.x.View ArticlePubMedGoogle Scholar

Copyright

© Caggiano et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.